申请人:MERCK PATENT GMBH
公开号:US20140148457A1
公开(公告)日:2014-05-29
Compounds of the formula I
in which R, R
1
, X and Y have the meanings indicated in Claim
1
, are inhibitors of TBK1 and IKKε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
公式I的化合物中,R、R1、X和Y的含义如权利要求1所示,可作为TBK1和IKKε的抑制剂,并可用于治疗癌症和炎症性疾病等。